Differential Repair of Platinum-DNA Adducts in Human Bladder and Testicular Tumor Continuous Cell Lines

Cancer Research

Volumn 48, Issue 11, 1988, Pages 3019-3024

  Bedford, Philip ^a   Fichtinger Schepman, Anne Marie ^a   Shellard, Sharon A ^a   Walker, M Claire ^a   Masters, John R ^b   Hill, Bridget T ^c  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b St Paul's School   (United Kingdom)

^c TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

BLADDER CARCINOMA; CELL CULTURE; DNA ADDUCT; DNA REPAIR; HUMAN; HUMAN CELL; TESTIS TUMOR; TUMOR CELL LINE;

BLADDER NEOPLASMS; CELL LINE; CELL SURVIVAL; CISPLATIN; DNA REPAIR; DNA REPLICATION; DNA, NEOPLASM; HUMAN; KINETICS; MALE; PLATINUM; RADIOISOTOPES; TESTICULAR NEOPLASMS;

EID: 0023937397     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Einhom, L. H., and Williams, S. D. The management of disseminated testicular cancer. In: S. K. Carter, E. Glatstein, and R. B. Livingston (eds.), Principles of Cancer Treatment, pp. 605–612. New York: McGraw-Hill, 1982.
2. Chabner, B. A., Fine, R. L., Allegra, C. J., Yeh, G. W., and Curt, G. A. Cancer chemotherapy progress and expectations. Cancer (Phila.), 54: 2599–2608, 1984.
3. Frei, E. Curative cancer chemotherapy. Cancer Res., 45:6523-6537, 1985.
4. Anderson, T. Chemotherapy of metastatic bladder cancer. In: S. K. Carter, E. Glatstein, and R. B. Livingston (eds.), Principles of Cancer Treatment, pp. 565–570. New York: McGraw-Hill, 1982.
5. Yagoda, A. Chemotherapy of metastatic bladder cancer. Cancer (Phila.), 45: 1879-1888, 1980.
6. Smith, P. M. Chemotherapy of bladder cancer A review. Cancer Treat. Rep., 65 (Suppl. 1): 165-173, 1981.
7. Walker, M. C., Parris, C. N., and Masters, J. R. W. Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs. J. Natl. Cancer Inst., 79:213-216, 1987.
8. Walker, M. C., Shaw, I. E., and Masters, J. R. W. Extra-hepatic metabolism of cyclophosphamide: a mechanism of differential tumour cell sensitivity? Br. J. Cancer, 56:221, 1987.
9. Parris, C. N., Arlett, C. F., Harcourt, S., and Masters, J. R. W. Differential radiosensitivity between human bladder and testicular tumour cell lines. Br. J. Cancer, 54: 175-176, 1986.
10. Hill, B. T., Whelan, R. D. H., Hosldng, L. K., Shellard, S. A., Bedford, P., and Lock, R. B. Interactions between antitumour drugs and radiation in mammalian tumor cell lines: differential drug responses and mechanisms of resistance following fractionated X-irradiation or continuous drug exposure in vitro. NCI Monogr., 6:177-181, 1988.
11. Roberts, J. J., Knox, R. J.,Friedlos, F., and Lydall, D. A. DNA as the target for the cytotoxic and antitumour action of platinum co-ordination complexes: comparative in vitro and in vivo studies of cisplatin and carboplatin. In: D. C. H. McBrien and T. F. Slater (eds.), Biochemical Mechanisms of Platinum Antitumour Drugs, pp. 29–64. Oxford, United Kingdom: IRL Press, 1986.
12. Zwelling, L. A., Anderson, T., and Kohn, K. W. DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum (II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res., 39: 365-369, 1979.
13. Plooy, A. C. M., Van Dijk, M., and Lohman, P. H. M. Induction and repair of DNA cross-links in Chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity. Cancer Res., 44: 2043–2051, 1984.
14. Pascoe, J. M., and Roberts, J. J. Interactions between mammalian cell DNA and inorganic platinum compounds. I. DNA interstrand cross-linking and cytotoxic properties of platinum(II) compounds. Biochem. Pharmacol., 23: 1345-1357, 1974.
15. Erickson, L. C., Zwelling, L. A., Ducore, J. M., Sharkey, N. A., and Kohn, K. W. Differential cytotoxicity and DNA cross-linking in normal and transformed human fibroblasts treated with cis-diamminedichloroplatinum(H). Cancer Res., 41:2791-2794, 1981.
16. Bedford, P., Walker, M. C., Sharma, H. L., Perera, A., McAuliffe, C. A., Masters, J. R. W., and Hill, B. T. Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloroplatinum(II). Chem.-Biol. Interact., 61:1-15, 1987.
17. Teicher, B. A., Holden, S. A., Kelley, M. J., Shea, T. C., Cucchi, C. A., Rosowsky, A., Henner, W. D., and Frei, E. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res., 47:388-393, 1987.
18. Meyn, R. E., Jenkins, S. F., and Thompson, L. H. Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster cells. Cancer Res., 42: 3106–3110, 1982.
19. Plooy, A. C. M., Van Dijk, M., Berends, F., and Lohman, P. H. M. Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis in control and mutant human cells treated with cis-diamminedichloroplatinum(Il). Cancer Res., 45:4178-4184, 1985.
20. Strandberg, M., Bresnick, E., and Eastman, A. The significance of DNA cross-linking to cu-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukaemia L1210. Chem.-Biol. Interact, 39:169-180, 1982.
21. Rawlings, C. J., and Roberts, J. J. Walker rat carcinoma cells are exceptionally sensitive to cis-diamminedichloroplatinum(II) (cisplatin) and other di-functional agents but not defective in the removal of platinum-DNA adducts. Mutat Res., 166:157-169, 1986.
22. Roberts, J. J., and Friedlos, F. Quantitative aspects of the formation and loss of DNA interstrand cross-links in Chinese hamster cells following treatment with cis-diamminedichloroplatinum(H) (cisplatin). I. Proportion of DNA-platinum reactions involved in cross-linking. Biochim. Biophys. Acta, 655: 146-151, 1981.
23. Fichtinger-Schepman, A. M. J., Lohman, P. H. M., and Reedijk, J. Detection and quantification of adducts formed upon interaction of diamminedichlo-roplatinum(II) with DNA, by anion exchange chromatography after enzymic degradation. Nucl. Acids Res., 10:5345-5356, 1982.
24. Fichtinger-Schepman, A. M. J., Van der Veer, J. L., den Hartog, J. H. J., Lohman, P. H. M., and Reedijk, J. Adducts of the antitumor drug cis- diamminedichloroplatinum(II) with DNA: formation, identification and quantification. Biochemistry, 24:707-713, 1985.
25. Eastman, A. Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(ll) and cis-dichloro(ethylene-diamine) plati-num(II). Biochemistry, 22:3927-3933, 1983.
26. Fichtinger-Schepman, A. M. J., Baan, R. A., Luiten-Schuite, A., van Dijk, M., and Lohman, P. H. M. Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum(II) and analysis of adduct related DNA-unwinding. Chem-Biol. Interact., 55: 275-288, 1985.
27. Fichtinger-Schepman, A. M. J., van Oosterom, A. T., Lohman, P. H. M., and Berends, F. cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochem-ical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II). Cancer Res., 47:3000-3004, 1987.
28. Kohn, K. W., Ewig, R. A. G., Erickson, L. C., and Zwelling, L. A. Measurement of strand breaks and cross-links by alkaline elution. In: E. C. Friedberg and P. C. Hanawalt (eds.), DNA Repair A Laboratory Manual of Research Procedures, Vol. 1, pp. 379–401. New York: Marcel Dekker, 1981.
29. Masters, J. R. W., Hepburn, P. J., Walker, L., Highman, W. J., Trejdosiew-icz, L. K., Povey, S., Parkar, M., Hill, B. T., Riddle, P. R., and Franks, L. M. Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial lines. Cancer Res., 46:3630-3636, 1986.
30. Bronson, D. L., Andrews, P. W., Solter, D., Cervenka, J., Lange, P. M., and Fracey, E. E. Cell line derived from a metastasis of a human testicular germ cell tumor. Cancer Res., 40:2500-2506, 1980.
31. Hogan B., Fellous, M., Avner, P., and Jacob, F. Isolation of a human teratoma cell line which expresses F9 antigen. Nature (Lond.), 270: 515–518, 1977.
32. Groos, E., Walker, L., and Masters, J. R. W. Intravesical chemotherapy: studies on the relationship between pH and cytotoxicity. Cancer (Phila.), 58: 1199-1203, 1986.
33. Burton, K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J., 62: 315-323, 1956.
34. Fichtinger-Schepman, A. M. J., Lohman, P. H. M., Berends, F., Reedijk, J., and Van Oosterom, A. T. Interactions of the antitumour drug cisplatin with DNA in vitro and in vivo. IARC Sci. Publ., 78:83-99, 1986.
35. Plooy, A. C. M., Fichtinger-Schepman, A. M. J., Schutte, H. H., van Dijk, M., and Lohman, P. H. M. The quantitative detection of various Pt-DNA adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques. Carcinogenesis (Lond.), 6:561-566, 1985.
36. Fraval, H. N. A., and Roberts, J. J. Excision repair of cis-diamminedichlo-roplatinum(I1)-induced damage to DNA of Chinese hamster cells. Cancer Res., 39:1793-1797, 1979.